Clinical Trial Update: Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA® [Phase 4]

View source ↗

Summary

Phase 4 trial update for EGRIFTA in HIV patients with diabetic retinopathy; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy
• HIV Infection

Drugs mentioned

• Egrifta (tesamorelin)

Snippet

Sponsor: Theratechnologies | Conditions: Diabetic Retinopathy, HIV | Phase 4 | Status: TERMINATED